Published in Mol Ther on December 21, 2010
Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors. PLoS One (2015) 0.75
Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol (1992) 13.15
Cellular uptake of the tat protein from human immunodeficiency virus. Cell (1988) 10.19
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem (1997) 6.52
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med (2004) 6.48
Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem (2002) 6.01
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (1990) 4.47
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol (1993) 3.68
Structural and functional characterization of human immunodeficiency virus tat protein. J Virol (1989) 3.57
A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic (2007) 3.01
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol (2009) 2.99
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem (2000) 2.98
Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res (2001) 2.54
Methods for construction of adenovirus vectors. Mol Biotechnol (1995) 2.37
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A (2000) 2.23
Development of a bidirectional caspase-3 expression system for the induction of apoptosis. Cancer Biol Ther (2008) 1.42
The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat Biotechnol (2001) 1.25
Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression. Biochem Biophys Res Commun (2002) 1.24
Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J (2010) 1.18
Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther (2002) 1.01
"Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms. Mol Ther (2003) 0.98
Delivery of therapeutic proteins as secretable TAT fusion products. Mol Ther (2008) 0.93
Furin cleavage of the HIV-1 Tat protein. FEBS Lett (2004) 0.92
Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo. Mol Ther (2003) 0.90
Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. Blood (2004) 0.89
HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Lett (2002) 0.89
Comparison of protein transduction domains in mediating cell delivery of a secreted CRE protein. Biochemistry (2008) 0.87
HIV-1 Tat is unconventionally secreted through the plasma membrane. Cell Biol Int (2010) 0.87
Correlation between hydrophobic properties and efficiency of carrier-mediated membrane transduction and apoptosis of a p53 C-terminal peptide. Biochem Biophys Res Commun (2002) 0.85
Production of cell lines secreting TAT fusion proteins. J Histochem Cytochem (2004) 0.84
Characteristics of HIV-Tat protein transduction domain. J Microbiol (2004) 0.81
Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo. Hum Gene Ther (2005) 0.81
Fusion of the human immunodeficiency virus type 1 tat protein transduction domain to thymidine kinase increases bystander effect and induces enhanced tumor killing in vivo. Hum Gene Ther (2005) 0.80
Secretion and uptake of TAT-fusion proteins produced by engineered mammalian cells. Biochim Biophys Acta (2008) 0.78
Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol (2003) 3.69
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points. Hum Gene Ther (2003) 1.35
Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein. Hum Gene Ther (2002) 1.05
Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus. Mol Ther (2007) 0.99
Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Crit Care Med (2008) 0.90
Drug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic. Curr Opin Mol Ther (2006) 0.90
Racial differences in potassium disposal. Kidney Int (2004) 0.88
Impact of E1a modifications on tumor-selective adenoviral replication and toxicity. Mol Ther (2004) 0.84
The utility of extended longitudinal profiles in predicting future health care expenditures. Med Care (2006) 0.79
New Drug for Sepsis on the Cheap? Crit Care Med (2015) 0.77
Hybrid optical materials of plasmon-coupled CdSe/ZnS coreshells for photonic applications. Opt Mater Express (2012) 0.75
How do changes in tumor matrix affect the outcome of virotherapy? Cancer Biol Ther (2007) 0.75
Plagiocephaly and Developmental Delay: A Systematic Review. J Dev Behav Pediatr (2017) 0.75
Therapeutic hypothermia after cardiac arrest in a patient with systemic sclerosis and Raynaud phenomenon. Chest (2015) 0.75
Gastrointestinal and renal excretion of potassium in African-Americans and White Americans. J Hypertens (2012) 0.75
Poster 285 Ultrasound Guided Diaphragmatic EMG in Patient with Respiratory Decline and Pre-Existing Contralateral Diaphragm Atrophy: A Case Report. PM R (2016) 0.75
Process Performance of Secondary Effluent Granular Media Filtration with and without Preozonation. Water Environ Res (2015) 0.75
Demonstrating Compliance with Stringent Nitrogen Limits Using a Biological Nutrient Removal Process in California's Central Valley. Water Environ Res (2015) 0.75